外媒报道中国SSDM
在刚过去不久的国际风湿界盛会——美国风湿病学会（ACR）年会上，中国智能疾病管理系统（Smart System of Disease Management，SSDM）因能降低患者的就医费用、提高疗效、改善用药安全、提高病人满意度而得到了极高的评价和认可。连续4天的正式会议中，SSDM先获得了ACR官网的报道，随后又做了口头发言，并在ACR媒体见面会上作为第一个推介项目发言，还应邀做为大会“特别壁报”进行巡讲。
国际著名医学媒体根据ACR发布会内容进行了跟进报道。近日，ACR组委会特地将此信息通报给SSDM团队，现在分享如下。☟
（肖飞：再次感谢您参加今年ACR年会的新闻发布会。看来很多人对您的发现感兴趣，已经有关于您工作的文章发表出来了：Healio Physician’s Briefing
关于您研究的报道或将陆续发布，今早我看到了这条报道，希望让您也得知！）
Healio对SSDM的报道，点击文末处的“阅读原文”即可跳转
关于Healio：
Healio.com是面向医疗卫生专业人员的新闻和教育信息网站。该网站提供深入的专业临床信息，其特色是提供行业内的新闻报道、动态多媒体、问答栏目、教育活动、快速参考内容、博客、同行评议期刊以及全线的热门图书信息。
该外媒的报道译文如下：
移动APP咨询降低RA患者的医疗保健成本
根据美国风湿病学会年度会议上的研究结果，类风湿关节炎（rheumatoid arthritis，RA）患者通过一种新颖的移动应用程序向风湿病专家咨询，已被证实显著降低了医疗成本，并促进了更有效的疾病管理。
该研究的第一作者肖飞（医学博士，欣凯公司CEO）介绍了智能疾病管理系统（Smart System of Disease Management）的研究成果。他将其描述为一系列基于临床数据的应用，其中包括患者可在手机上使用的咨询工具。
他说，“通过使用这个APP，患者能够参与到自己疾病的管理中”。
在美国风湿病学会年度会议的新闻发布会上，肖飞（医学博士）指出，基于该移动APP的医疗咨询使患者就医成本节省了大约6倍。
目前的研究包括403名风湿病学专家为研究人员提供的4002名患者的数据。在该队列中，42%为RA患者、21%为系统性红斑狼疮、11%为强直性脊柱炎、10%为痛风、5%为骨关节炎、3%为干燥综合征、7%为其他风湿病。
数据收集自2015年2月至2017年6月，包括293次免费咨询和3709次付费咨询。在付费咨询中，3983次问答是文字形式的，19次是通过语音进行的。
患者支付了10元至500元人民币（汇率，1美元=6.81人民币）进行咨询。每次咨询的平均费用为96.06±38.61元，研究人员称，这与医院挂号费相当。咨询费总额为477960元人民币。
肖飞补充道，该APP“鼓励医生将患者照片上传到一组网络，建立一个知识网络”。
另一项研究结果显示，在接受在线咨询的队列中，有35.3%的患者居住在与风湿病专家不同的城市。肖飞指出，在医院寻求医疗服务的总成本为565.17±510.49元，其中包括挂号费、医疗费、交通费、住宿费和伙食费，以及工资损失。当计算所有患者的这些费用时，总额将达到3157220元人民币。这个总成本比在线咨询成本高6.61倍。报告这个数字的另一种说法是，该APP可使患者成本节省84.86%。
肖飞说：“该移动APP平台节省了6倍的就医费用”。
患者调查的结果表明，所有患者均报告满意，其中66.35%的患者表示，他们对在线咨询“非常满意”。
肖飞说：“良好的疾病管理优于良药”（Good disease management is better than medicine）。
报道原文如下 ☟
SAN DIEGO — Consultation with rheumatologist via a novel, mobile application demonstrated significant health care cost savings for patients with rheumatoid arthritis, and encouraged more efficient disease management , according to findings presented at the American College of Rheumatology Annual Meeting.
Fei Xiao, MD, CEO of Cinkate Corporation and a lead author of the study, presented findings for the Smart System of Disease Management. He described it as aseries of applications based on clinical data that include a consultation tool that patients may use from their mobile phones.
“Using this app, patients are able to participate in their own care,” he said.
The current study included information from 403 rheumatologists who provided researchers with data for 4,002 patients. The cohort was 42% patients with RA,21% with systemic lupus erythematosus, 11% with ankylosing spondylitis, 10% with gout, 5% with osteoarthritis, 3% with Sjögren’s syndrome and 7% with other rheumatic diseases.
Data were collected from February 2015 through June 2017 and included 293 consultations and 3,709 paid consultations. Of the paid consultations, 3,983 were text question-and-answer exchanges, while 19 were conducted using voice communications.
Patients paid a range of RMB 10 to 500 yuan (exchange rate, 1 U.S.dollar = 6.81 renminbi [RMB]) for consultations. Eachconsultation averaged 96.06 ± 38.61 yuan, which the researchers noted matched hospital registration fees. Consultation fees totaled 477,960 yuan RMB.
Xiao added that the app “encourages physicians to take pictures of patients to upload to a group network, building a network of knowledge.”
Another finding showed 35.3% of the cohort that received consultations on line were located in a different city than the rheumatologist. Xiao noted that seeking care in a hospital carried an overall cost of 565.17 ± 510.49 yuan, which included registration fees, medical expenses, transportation, accommodation and food costs, in addition to lost wages from work. When these cost for all patients were tallied, the total would have been 3,157,220 yuan RMB. This total cost was 6.61-times higher than would have been incurred via online consultation.Another way of reporting this figure is to say the app could save 84.86% of patient costs.
“The mobile app platform saved six-times the cost of care,” Xiao said.
Results of a patient survey indicated that all patients reported satisfaction, while 66.35 noted the online consultations left them “very satisfied.”
“Good disease management is better than medicine,” Xiao said. —by Rob Volansky
Reference:
Xiao F, et al. Abstract 928. Presented at: American College of Rheumatology Annual Meeting; Nov. 4-8, 2017; San Diego.
Disclosures: Xiao reports norelevant financial disclosures. Please see the full study for a complete list of all other authors’ relevant financial disclosures.
▷ 2017美国风湿病大会，世界聚焦中国使用SSDM进行疾病管理的进展
▷ ACR 2017官方新闻发布会：iRheum（智能风湿）
▷ 【ACR 2017 | 壁报日】Poster Tour上中国SSDM再次成焦点
扫码下载SSDM